Acute Kidney Injury in Patients Receiving Anti-Tuberculosis Treatment

Auteur/ices

  • Madiha Mehmood Department of Nephrology, King Edward Medical Universiy, Lahore, Pakistan
  • Muhammad Anees Department of Nephrology, King Edward Medical Universiy, Lahore, Pakistan

DOI :

https://doi.org/10.53778/pjkd92302

Mots-clés :

acute kidney injury, anti tuberculous treatment, ATT, Rifampicin, Isoniazid, AKI

Résumé

Although life-saving, anti-tuberculosis therapy (ATT) carries the risk of acute kidney injury (AKI), potentially complicating its management.

 

Methods: 102 subjects starting on ATT were followed for 2 months. Presence of AKI was documented with monitoring of kidney functions.

Results:

AKI was observed among 14.7% patients, predominantly affecting middle-aged males.

Conclusion:

Early recognition of AKI by monitoring for kidney function is crucial for reducing the risk of long-term sequelae of kidney failure among patients taking ATT.

PJKD

Téléchargements

Publiée

2025-06-30

Numéro

Vol. 9 No 2 (2025): Pakistan Journal of Kidney Diseases

Rubrique

Original Article

Licence

Merci de créditer les auteurs lors de toute citation : Madiha Mehmood, Dr Muhammad Anees (2025)

Creative Commons License

Ce travail est disponible sous licence Creative Commons Attribution - Pas d’Utilisation Commerciale 4.0 International.

Comment citer

Acute Kidney Injury in Patients Receiving Anti-Tuberculosis Treatment. (2025). Pakistan Journal of Kidney Diseases, 9(2), 16-19. https://doi.org/10.53778/pjkd92302